Atsushi Osoegawa

Yufu, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan.

Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan.

Journal: Cancer science
Published: December 22, 2025

Narrative review of descending necrotizing mediastinitis, focusing on the etiology, classification-guided surgical management, treatments, and prognosis.

Narrative review of descending necrotizing mediastinitis, focusing on the etiology, classification-guided surgical management, treatments, and prognosis.

Journal: Mediastinum (Hong Kong, China)
Published: October 10, 2025

Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2.

Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2.

Journal: Cancer science
Published: October 06, 2025

Relationship between immune-related adverse events and treatment outcome of immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective cohort study.

Relationship between immune-related adverse events and treatment outcome of immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective cohort study.

Journal: Journal of thoracic disease
Published: September 26, 2025

A Case of Mediastinitis Due to Fulminant Group A Streptococcal Infection.

A Case of Mediastinitis Due to Fulminant Group A Streptococcal Infection.

Journal: Surgical case reports
Published: September 25, 2025

Successful treatment of lung squamous cell carcinoma with envafolimab, a PD-L1 inhibitor combined with chemotherapy: a case report.

Successful treatment of lung squamous cell carcinoma with envafolimab, a PD-L1 inhibitor combined with chemotherapy: a case report.

Journal: Translational cancer research
Published: September 22, 2025

Atezolizumab + Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2).

Atezolizumab + Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2).

Journal: Cancer science
Published: May 06, 2025

A Rare Case of Male Breast Cancer Presenting as a Superficial Pigmented Nipple Tumor: The Importance of a Deep Excisional Biopsy and Immunohistochemical Analysis in Diagnosis.

A Rare Case of Male Breast Cancer Presenting as a Superficial Pigmented Nipple Tumor: The Importance of a Deep Excisional Biopsy and Immunohistochemical Analysis in Diagnosis.

Journal: Cureus
Published: May 02, 2025

Pathological Complete Response in Locally Advanced ALK Fusion Gene-Positive Lung Adenocarcinoma following Salvage Surgery: A Case Report and Literature Review.

Pathological Complete Response in Locally Advanced ALK Fusion Gene-Positive Lung Adenocarcinoma following Salvage Surgery: A Case Report and Literature Review.

Journal: Surgical case reports
Published: April 23, 2025

Clinical Outcomes and Safety of Concurrent Chemoradiotherapy in EGFR-Mutant Unresectable Stage III NSCLC.

Clinical Outcomes and Safety of Concurrent Chemoradiotherapy in EGFR-Mutant Unresectable Stage III NSCLC.

Journal: JTO clinical and research reports
Published: April 09, 2025

Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study.

Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study.

Journal: JTO clinical and research reports
Published: March 28, 2025

Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells.

Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells.

Journal: Cell death discovery
Published: February 15, 2025
Showing 1-12 of 74

Last Updated: 09/26/2026